Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
Authors:
Open Access
- 1 January 2015
- journal article
- review article
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-12
Abstract
Objective. More and more evidences demonstrate that androgen receptor (AR), epidermal growth factor receptor (EGFR), and breast cancer susceptibility gene 1 (BRCA1) have unique clinical implications for targeted therapy or prognosis in triple-negative breast cancer (TNBC). Therefore, we conducted a meta-analysis to summarize the possible associations.Methods. We retrieved published articles about AR, EGFR, and BRCA1 in TNBC from PubMed and EMBASE. The analysis was performed with Rev-Man 5.2 software.Results. A total of 38 articles were eligible for the meta-analysis. Our study showed that the expression level of EGFR (,) and the prevalence of BRCA1 mutation (,) were higher in TNBC than non-TNBC. In contrast, the expression level of AR was lower in TNBC than non-TNBC (,). In the subgroup related to EGFR expression, the level of EGFR expression was significantly increased in Asians () compared with Caucasians () for TNBC patients. Additionally, the prevalence of BRCA1 mutation in Asians (,) was higher than that in Caucasians (,).Conclusions. The distinct expression of AR and EGFR and the prevalence of BRCA1 mutation indicated that AR, EGFR, and BRCA1 might be unique biomarkers for targeted therapy and prognosis in TNBC.
Keywords
Funding Information
- National Natural Science Foundation of China (30873044, 81272372)
- National Natural Science Foundation of China (30873044, 81272372)
This publication has 58 references indexed in Scilit:
- Prevalence ofBRCA1andBRCA2Germline Mutations in Breast Cancer Women of Multiple Ethnic Region in Northwest ChinaJournal of Breast Cancer, 2013
- Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal WomenClinical Cancer Research, 2011
- Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi WomenBreast Cancer Research and Treatment, 2011
- Clinical and pathological characteristics of Chinese patients with BRCA related breast cancerThe HUGO Journal, 2009
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal SubtypesClinical Cancer Research, 2009
- Triple negative tumours: a critical reviewHistopathology, 2007
- Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patientsBreast Cancer Research and Treatment, 2007
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002